title: [Expression and activity determination of recombinant capsid protein VP2 gene of enterovirus type 71].
abstract: OBJECTIVE
  To clone and express the recombinant capsid protein VP2 of enterovirus type 71 (EV71) and to identify the immune activity of expressed protein in order to build a basis for the investigation work of vaccine and diagnostic antigen.
  
  
  METHODS
  VP2 gene of EV71 was amplified by PCR, and then was cut by restriction enzyme and inserted into expression vector pMAL-c2X. The positive recombinants were transferred into E.coli TB1, the genetically engineered bacteria including pMAL-c2X-VP2 plasmids were induced by isopropyl thiogalactoside ( IPTG) , and the expression products were analyzed by SDS-PAGE and western blotting method. EV71 IgM antibody detection method by ELISA was set up, and the sensitivity and specificity of this method was assessed; 60 neutralizing antibody positive serum samples from hand foot and mouth disease (HFMD) patients were determined, of which 52 samples were positive and 8 samples were negative; a total of 88 acute phase serum samples of HFMD patients diagnosed in clinical were also detected.
  
  
  RESULTS
  VP2 gene of 762 bp was obtained by PCR, the gene segment inserted into the recombinant vector was identified using restriction enzyme digestion. The recombinant vector could express a specific about 71 500 fusion protein in E.coli by SDS-PAGE. The purified recombinant protein of EV71-VP2 can react with the serum of HFMD patients to produce a specific band by western blotting. The sensitivity and specificity of ELISA was 87% and 83%, respectively. Of the 88 acute phase serum samples from children with HFMD, 48 samples (55%) were positive by the ELISA assay.
  
  
  CONCLUSIONS
  VP2 gene of EV71 has been cloned and a prokaryotic high expression system for VP2 gene was successfully constructed in the present study. The recombination EV71-VP2 has well antigenicity, which could be useful for developing diagnose reagent or vaccine of EV71.
authors: Institute for Infectious Disease Control and Prevention, Henan Provincial Center for Disease Prevention and Control, Zhengzhou 450016, China.
authors: Xueyong
authors: X
authors: Huang
authors: Guohua
authors: G
authors: Liu
authors: Xiaoning
authors: X
authors: Hu
authors: Yanhua
authors: Y
authors: Du
authors: Xingle
authors: X
authors: Li
authors: Yuling
authors: Y
authors: Xu
authors: Haomin
authors: H
authors: Chen
authors: Email: xubl@hncdc.com.cn.
authors: Bianli
authors: B
authors: Xu
mesh_terms: D057134:Antibodies, Neutralizing / Q000097:blood; D000914:Antibodies, Viral / Q000097:blood; D036022:Capsid Proteins / Q000235:genetics* / Q000276:immunology*; D029821:Enterovirus A, Human / Q000235:genetics* / Q000276:immunology / Q000302:isolation & purification; D004797:Enzyme-Linked Immunosorbent Assay; D005822:Genetic Vectors; D006232:Hand, Foot and Mouth Disease / Q000276:immunology; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology
chemical_list: D057134:Antibodies, Neutralizing; D000914:Antibodies, Viral; D036022:Capsid Proteins; D007075:Immunoglobulin M; D011994:Recombinant Proteins